FDA 483 - Nanophase Technologies Corporation - April 13, 2023

Nanophase Technologies Corporation in Romeoville, IL, was inspected by the FDA, revealing significant data integrity and quality control issues. The firm failed to implement unique user access controls for analytical equipment and did not adequately verify raw material supplier Certificates of Analysis. These observations indicate a moderate level of non-compliance with good manufacturing practices.